Relias V - Search Results

1

A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approach.

Saif MW, Lee AM, Offer SM, McConnell K, Relias V, Diasio RB. Saif MW, et al. Among authors: relias v. Mayo Clin Proc. 2014 Jan;89(1):131-136. doi: 10.1016/j.mayocp.2013.09.008. Mayo Clin Proc. 2014. PMID: 24388031 Free PMC article.

2

Does "OPTINAB" strategy ("stop-and-go") work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel-gemcitabine?

Relias V, Maloney A, Smith MH, Saif MW. Relias V, et al. Cancer Chemother Pharmacol. 2017 Aug;80(2):371-375. doi: 10.1007/s00280-017-3374-x. Epub 2017 Jun 29. Cancer Chemother Pharmacol. 2017. PMID: 28664225

3

BRCA and pancreatic cancer.

Brennan GT, Relias V, Saif MW. Brennan GT, et al. Among authors: relias v. JOP. 2013 Jul 10;14(4):325-8. doi: 10.6092/1590-8577/1652. JOP. 2013. PMID: 23846919 Free article. Review.

4

Biological identification of ampullary adenocarcinomas.

Relias V, Saif MW. Relias V, et al. JOP. 2014 Jul 28;15(4):306-7. doi: 10.6092/1590-8577/2674. JOP. 2014. PMID: 25076327 Free article.

5

Safety and Efficacy of Same-Day Administration of Pegfilgrastim in Patients Receiving Chemotherapy for Gastrointestinal Malignancies.

Matera RM, Relias V, Saif MW. Matera RM, et al. Among authors: relias v. Cancer Med J. 2021 Apr 1;4(1):6-11. Epub 2020 May 18. Cancer Med J. 2021. PMID: 32656544 Free PMC article.

6

Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer.

Saif MW, Relias V, Syrigos K, Gunturu KS. Saif MW, et al. Among authors: relias v. World J Clin Oncol. 2014 Dec 10;5(5):1028-35. doi: 10.5306/wjco.v5.i5.1028. World J Clin Oncol. 2014. PMID: 25493238 Free PMC article. Review.

7

Management of regorafenib-related toxicities: a review.

Krishnamoorthy SK, Relias V, Sebastian S, Jayaraman V, Saif MW. Krishnamoorthy SK, et al. Among authors: relias v. Therap Adv Gastroenterol. 2015 Sep;8(5):285-97. doi: 10.1177/1756283X15580743. Therap Adv Gastroenterol. 2015. PMID: 26327919 Free PMC article. Review.

8

Chronic Use of Long-Acting Somatostatin Analogues (SSAs) and Exocrine Pancreatic Insufficiency (EPI) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Under-recognized Adverse Effect.

Saif MW, Romano A, Smith MH, Patel R, Relias V. Saif MW, et al. Among authors: relias v. Cancer Med J. 2020;3(2):75-84. Epub 2020 Apr 27. Cancer Med J. 2020. PMID: 32405630 Free PMC article.

9

Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors.

Saif MW, Fu J, Smith MH, Weinstein B, Relias V, Daly KP. Saif MW, et al. Among authors: relias v. J Pancreat Cancer. 2018 Oct 1;4(1):64-71. doi: 10.1089/pancan.2018.0013. eCollection 2018. J Pancreat Cancer. 2018. PMID: 30788459 Free PMC article.

10

Racial Differences in Accepting Pegfilgrastim Onpro Kit (On-Body Injector) Use Among Cancer Patients.

Saif MW, Hackenyos DW, Smith MH, Healey P, Relias V, Wasif K. Saif MW, et al. Among authors: relias v. Clin Oncol (Las Vegas). 2019;1(6):1026. Epub 2019 Feb 25. Clin Oncol (Las Vegas). 2019. PMID: 31406963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters